CNBC February 12, 2025
Key Points
– CVS Health CEO David Joyner defended controversial pharmacy middlemen, who are widely accused of inflating prescription medication prices, and instead accused manufacturers of “monopolistic” practices that keep drug costs high in the U.S.
– Joyner, who stepped into the role in October, spent much of his opening remarks on the company’s fourth-quarter earnings call discussing so-called pharmacy benefit managers, or PBMs.
– It comes at a time when lawmakers on both sides of the aisle and President Donald Trump have signaled interest in cracking down on PBMs.
CVS Health CEO David Joyner on Wednesday defended controversial pharmacy middlemen like his company’s Caremark unit, which are widely accused of inflating prescription medication prices, and instead...
Today's Sponsors
Today's Sponsor